Literature DB >> 28827371

STRAP Promotes Stemness of Human Colorectal Cancer via Epigenetic Regulation of the NOTCH Pathway.

Lin Jin1,2, Trung Vu1, Guandou Yuan1, Pran K Datta3,2.   

Abstract

NOTCH signaling exerts essential roles in normal and malignant intestinal physiology and the homeostasis of cancer stem-like cells (CSC), but the basis for this latter role remains obscure. The signaling scaffold protein STRAP is upregulated in several cancers, where it promotes tumorigenicity and metastasis. Here we report a novel oncogenic function for STRAP in maintaining CSC subpopulations in a heterogeneous mixture by antagonizing formation of the chromatin modifier PRC2 and by epigenetically activating NOTCH signals in human colorectal cancer. Silencing STRAP sensitized colorectal cancer cells to chemotherapeutic drugs in vitro and in vivo STRAP depletion also contributed to a reduced stem-like phenotype of colorectal cancer cells, as indicated by reduced expression of the CSC signature and NOTCH signaling regulators in vitro and by diminished tumorigenesis in vivo Genes encoding some upstream activators of NOTCH were highly enriched for H3K27me3, which forms repressive chromatin domains upon STRAP silencing. Mechanistically, STRAP competitively disrupted association of the PRC2 subunits EZH2 and SUZ12, thereby inhibiting PRC2 assembly. Restoring the NOTCH pathway by lentiviral expression of NICD1 or HES1 in STRAP-depleted tumor cells reversed the CSC phenotype. In 90 colorectal cancer clinical specimens, a significant positive correlation was documented between the expression of STRAP and HES1. Overall, our findings illuminated a novel STRAP-NOTCH1-HES1 molecular axis as a CSC regulator in colorectal cancer, with potential implications to improve treatment of this disease. Cancer Res; 77(20); 5464-78. ©2017 AACR. ©2017 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28827371      PMCID: PMC5645244          DOI: 10.1158/0008-5472.CAN-17-0286

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  46 in total

1.  Molecular cloning and characterization of human MAWD, a novel protein containing WD-40 repeats frequently overexpressed in breast cancer.

Authors:  S Matsuda; R Katsumata; T Okuda; T Yamamoto; K Miyazaki; T Senga; K Machida; A A Thant; S Nakatsugawa; M Hamaguchi
Journal:  Cancer Res       Date:  2000-01-01       Impact factor: 12.701

Review 2.  The Notch signaling pathway: molecular basis of cell context dependency.

Authors:  Ralf Schwanbeck; Simone Martini; Kristina Bernoth; Ursula Just
Journal:  Eur J Cell Biol       Date:  2010-12-03       Impact factor: 4.492

Review 3.  The role of pluripotency factors to drive stemness in gastrointestinal cancer.

Authors:  Martin Müller; Patrick C Hermann; Stefan Liebau; Clair Weidgang; Thomas Seufferlein; Alexander Kleger; Lukas Perkhofer
Journal:  Stem Cell Res       Date:  2016-02-03       Impact factor: 2.020

Review 4.  Cancer stem cells: an evolving concept.

Authors:  Long V Nguyen; Robert Vanner; Peter Dirks; Connie J Eaves
Journal:  Nat Rev Cancer       Date:  2012-01-12       Impact factor: 60.716

5.  Transcription Factor ZBP-89 Drives a Feedforward Loop of β-Catenin Expression in Colorectal Cancer.

Authors:  Bryan E Essien; Sinju Sundaresan; Ramon Ocadiz-Ruiz; Aaron Chavis; Amy C Tsao; Arthur J Tessier; Michael M Hayes; Amanda Photenhauer; Milena Saqui-Salces; Anthony J Kang; Yatrik M Shah; Balazs Győrffy; Juanita L Merchant
Journal:  Cancer Res       Date:  2016-10-10       Impact factor: 12.701

6.  Cancer stem cell markers CD133 and CD24 correlate with invasiveness and differentiation in colorectal adenocarcinoma.

Authors:  Dongho Choi; Hyo-Won Lee; Kyung-Yul Hur; Jae-Joon Kim; Gyeong-Sin Park; Si-Hyong Jang; Young-Soo Song; Ki-Seok Jang; Seung-Sam Paik
Journal:  World J Gastroenterol       Date:  2009-05-14       Impact factor: 5.742

7.  Chemotherapy and cancer stem cells.

Authors:  Jeremy N Rich; Shideng Bao
Journal:  Cell Stem Cell       Date:  2007-10-11       Impact factor: 24.633

8.  Slow proliferation as a biological feature of colorectal cancer metastasis.

Authors:  A Anjomshoaa; S Nasri; B Humar; J L McCall; A Chatterjee; H-S Yoon; L McNoe; M A Black; A E Reeve
Journal:  Br J Cancer       Date:  2009-08-04       Impact factor: 7.640

9.  Genomic deregulation of the E2F/Rb pathway leads to activation of the oncogene EZH2 in small cell lung cancer.

Authors:  Bradley P Coe; Kelsie L Thu; Sarit Aviel-Ronen; Emily A Vucic; Adi F Gazdar; Stephen Lam; Ming-Sound Tsao; Wan L Lam
Journal:  PLoS One       Date:  2013-08-15       Impact factor: 3.240

10.  Hes1 is involved in the self-renewal and tumourigenicity of stem-like cancer cells in colon cancer.

Authors:  Fei Gao; YuQin Zhang; ShengChun Wang; YuanQiang Liu; Lin Zheng; JianQuan Yang; Wei Huang; YanFen Ye; WeiRen Luo; Dong Xiao
Journal:  Sci Rep       Date:  2014-02-04       Impact factor: 4.379

View more
  32 in total

Review 1.  Colorectal cancer: genetic abnormalities, tumor progression, tumor heterogeneity, clonal evolution and tumor-initiating cells.

Authors:  Ugo Testa; Elvira Pelosi; Germana Castelli
Journal:  Med Sci (Basel)       Date:  2018-04-13

2.  MYCN-mediated regulation of the HES1 promoter enhances the chemoresistance of small-cell lung cancer by modulating apoptosis.

Authors:  Qin Tong; Shuming Ouyang; Rui Chen; Jie Huang; Linlang Guo
Journal:  Am J Cancer Res       Date:  2019-09-01       Impact factor: 6.166

3.  STRAP: A Bridge Between Mutant APC and Wnt/ß-Catenin Signaling in Intestinal Cancer.

Authors:  Lopa Mishra
Journal:  Gastroenterology       Date:  2021-10-19       Impact factor: 22.682

4.  RASSF1A disrupts the NOTCH signaling axis via SNURF/RNF4-mediated ubiquitination of HES1.

Authors:  Andriani Angelopoulou; Ioanna Mourkioti; Aikaterini Polyzou; Angelos Papaspyropoulos; Daniela Pankova; Konstantinos Toskas; Simone Lanfredini; Anastasia A Pantazaki; Nefeli Lagopati; Athanassios Kotsinas; Konstantinos Evangelou; Efstathios Chronopoulos; Eric O'Neill; Vassilis Gorgoulis
Journal:  EMBO Rep       Date:  2021-12-13       Impact factor: 9.071

5.  Comprehensive analysis of the BC200 ribonucleoprotein reveals a reciprocal regulatory function with CSDE1/UNR.

Authors:  Evan P Booy; Ewan Ks McRae; Peyman Ezzati; Taegi Choi; Daniel Gussakovsky; Sean A McKenna
Journal:  Nucleic Acids Res       Date:  2018-11-30       Impact factor: 16.971

Review 6.  Genomic landscape of colorectal carcinogenesis.

Authors:  Jin Cheon Kim; Walter F Bodmer
Journal:  J Cancer Res Clin Oncol       Date:  2022-01-20       Impact factor: 4.553

7.  Serine-threonine Kinase Receptor-Associated Protein is a Critical Mediator of APC Mutation-Induced Intestinal Tumorigenesis Through a Feed-Forward Mechanism.

Authors:  Trung Vu; Arunima Datta; Carolyn Banister; Lin Jin; Guandou Yuan; Temesgen Samuel; Sejong Bae; Isam-Eldin Eltoum; Upender Manne; Bixiang Zhang; Robert S Welner; Kasturi Mitra; Phillip Buckhaults; Pran K Datta
Journal:  Gastroenterology       Date:  2021-09-11       Impact factor: 33.883

8.  Serine-Threonine Kinase Receptor Associate Protein (STRAP) confers an aggressive phenotype in neuroblastoma via regulation of Focal Adhesion Kinase (FAK).

Authors:  Laura V Bownes; Raoud Marayati; Colin H Quinn; Sara C Hutchins; Jerry E Stewart; Joshua C Anderson; Christopher D Willey; Pran K Datta; Elizabeth A Beierle
Journal:  J Pediatr Surg       Date:  2022-02-14       Impact factor: 2.549

Review 9.  Current understanding of epigenetics mechanism as a novel target in reducing cancer stem cells resistance.

Authors:  Saeedeh Keyvani-Ghamsari; Khatereh Khorsandi; Azhar Rasul; Muhammad Khatir Zaman
Journal:  Clin Epigenetics       Date:  2021-05-29       Impact factor: 6.551

10.  Serine-Threonine Kinase Receptor-Associated Protein (STRAP) Knockout Decreases the Malignant Phenotype in Neuroblastoma Cell Lines.

Authors:  Laura V Bownes; Adele P Williams; Raoud Marayati; Colin H Quinn; Sara C Hutchins; Jerry E Stewart; Trung Vu; Juliet L Easlick; Elizabeth Mroczek-Musulman; David K Crossman; Joshua C Anderson; Christopher D Willey; Pran K Datta; Elizabeth A Beierle
Journal:  Cancers (Basel)       Date:  2021-06-26       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.